ARVN Valuation

Arvinas Inc

Add to Watchlist

Advanced Chart

6.290

+0.05(0.801%)1D

Overview
Forecast
Valuation
Earnings

ARVN Relative Valuation

ARVN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ARVN is overvalued; if below, it's undervalued.

Historical Valuation

Arvinas Inc (ARVN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.82 is considered Undervalued compared with the five-year average of 77.52. The fair price of Arvinas Inc (ARVN) is between 10.23 to 20.27 according to relative valuation methord. Compared to the current price of 6.29 USD , Arvinas Inc is Undervalued By 38.54%.

Relative Value

Fair Zone

10.23-20.27

Current Price：6.29

38.54%

Undervalued

-2.01

Trailing

Forward

6.29

EV/EBITDA

Arvinas Inc. (ARVN) has a current EV/EBITDA of 6.29. The 5-year average EV/EBITDA is -14.48. The thresholds are as follows: Strongly Undervalued below -109.48, Undervalued between -109.48 and -61.98, Fairly Valued between 33.02 and -61.98, Overvalued between 33.02 and 80.52, and Strongly Overvalued above 80.52. The current Forward EV/EBITDA of 6.29 falls within the Historic Trend Line -Fairly Valued range.

1.87

EV/EBIT

Arvinas Inc. (ARVN) has a current EV/EBIT of 1.87. The 5-year average EV/EBIT is -28.70. The thresholds are as follows: Strongly Undervalued below -231.48, Undervalued between -231.48 and -130.09, Fairly Valued between 72.69 and -130.09, Overvalued between 72.69 and 174.07, and Strongly Overvalued above 174.07. The current Forward EV/EBIT of 1.87 falls within the Historic Trend Line -Fairly Valued range.

2.82

Arvinas Inc. (ARVN) has a current PS of 2.82. The 5-year average PS is 25.54. The thresholds are as follows: Strongly Undervalued below -26.28, Undervalued between -26.28 and -0.37, Fairly Valued between 51.45 and -0.37, Overvalued between 51.45 and 77.36, and Strongly Overvalued above 77.36. The current Forward PS of 2.82 falls within the Historic Trend Line -Fairly Valued range.

-2.72

P/OCF

Arvinas Inc. (ARVN) has a current P/OCF of -2.72. The 5-year average P/OCF is -3.82. The thresholds are as follows: Strongly Undervalued below -35.71, Undervalued between -35.71 and -19.77, Fairly Valued between 12.12 and -19.77, Overvalued between 12.12 and 28.06, and Strongly Overvalued above 28.06. The current Forward P/OCF of -2.72 falls within the Historic Trend Line -Fairly Valued range.

-2.71

P/FCF

Arvinas Inc. (ARVN) has a current P/FCF of -2.71. The 5-year average P/FCF is -7.15. The thresholds are as follows: Strongly Undervalued below -34.39, Undervalued between -34.39 and -20.77, Fairly Valued between 6.47 and -20.77, Overvalued between 6.47 and 20.09, and Strongly Overvalued above 20.09. The current Forward P/FCF of -2.71 falls within the Historic Trend Line -Fairly Valued range.

Arvinas Inc (ARVN) has a current Price-to-Book (P/B) ratio of 0.75. Compared to its 3-year average P/B ratio of 2.85 , the current P/B ratio is approximately -73.73% higher. Relative to its 5-year average P/B ratio of 3.90, the current P/B ratio is about -80.76% higher. Arvinas Inc (ARVN) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -19.52%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -9.80% , the current FCF yield is about -100.00% lower.

0.75

P/B

Median3y

2.85

Median5y

3.90

0.00

FCF Yield

Median3y

-19.52

Median5y

-9.80

Competitors Valuation Multiple

The average P/S ratio for ARVN's competitors is 8.68, providing a benchmark for relative valuation. Arvinas Inc Corp (ARVN) exhibits a P/S ratio of 2.82, which is -67.55% above the industry average. Given its robust revenue growth of -70.72%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Bicycle Therapeutics PLC

Solid Biosciences Inc

Loss

487.57M

Performance Decomposition

Market capitalization of ARVN decreased by 75.96% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -46.01 to -273.21.

The secondary factor is the Revenue Growth, contributed -70.72%to the performance.

Overall, the performance of ARVN in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-70.72%

76.50M → 22.40M

Revenue Growth

493.81%

-46.01 → -273.21

Margin Expansion

-499.05%

1.56 → -6.23

P/E Change

-75.96%